MRD / Regn No. : 6209 Date : 19/06/2026
Patient Name : Bharti Devi Bagla Age & Gender : 80 Yrs. / Female
Contact No. : 9831070686 UHID :
Ht / Wt / BMI : 157 / 85 / 34.48 BP S / BP D : 144 / 83
Allergies : NKA Referred By :
   
Problem List : TYPE 2 DIABETES (19/Oct/2007) | HYPERTENSION (19/Oct/2022) |
Salient Investigations : CREATININE: 1.02 | EGFR EGLOMERULAR FILTRATION RATE: 55.81 mL/min/1.73m2 | FASTING PLASMA GLUCOSE (FPG): 169 mg/dL | HB HEMOGLOBIN: 12.8 g/dL | HBA1C GLYCOSYLATED HEMOGLOBIN: 8.9 % | LDL LOW DENSITY LIPOPROTEIN: 50 mg/dL
S# Generic (Trade) Name Route Dosage Usage Duration
1 AMLODIPINE 5 MG + TELMISARTAN 40 MG
STAMLO T 40 MG
PO 1-0-1 BEFORE BREAKFAST AND DINNER
TILL NEXT VISIT
2 ROSUVASTATIN 10 MG
CRESTOR 10 MG
PO 0-0-1 BEFORE FOOD
TILL NEXT VISIT
3 DAPAGLIFLOZIN 10 MG METFORMIN XR 1000 MG
UDAPA M XR
PO 1-0-0 BEFORE BREAKFAST
TILL NEXT VISIT
4 TABLET ACARBOSE 50 MG
GLUCOBAY 50 MG
Medicine For DIABETES
PO 0-1-0 BEFORE LUNCH
TILL NEXT VISIT
5 INJECTION DEGLUDEC / ASPART (INJ U100) 70/30
RYZODEG
Medicine For DIABETES
SQ 28-0-20 BEFORE BREAKFAST AND DINNER
TILL NEXT VISIT
MAY CAUSE HYPOGLYCEMIA
       
Refill : 0 / Substitution:    
Education :
Next Visit : 19/Dec/2026
Tests Suggested For Next Visit : HBA1C-HPLC METHOD,UACR: SPOT SAMPLE,RETINA CHECK UP
   
   
User-Profile-Image
Dr. Samit Ghosal
MD (GM), Diploma in Diabetes Cardiff University, MSc (Diabetes Care) Glamorgan University, Diploma in Endocrinology Glamorgan University (USW), SCOPE certification in obesity management
West Bengal / 54020

This is a Computer generated Prescription

Powered By: